Document is current
Any future updates will be listed below
-
Authors
Wetzel, Katherine S. https://orcid.org/0000-0002-5364-5705
Illouz, Morgane https://orcid.org/0009-0001-4732-8631
Abad, Lawrence
Aull, Haley G.
Russell, Daniel A. https://orcid.org/0000-0001-6894-2748
Garlena, Rebecca A.
Cristinziano, Madison
Malmsheimer, Silke
Chalut, Christian https://orcid.org/0000-0002-4849-1369
Hatfull, Graham F. https://orcid.org/0000-0002-6705-6821
Kremer, Laurent https://orcid.org/0000-0002-6604-4458
-
Funding
Funding for this research was provided by:
U.S. Department of Health and Human Services | National Institutes of Health (GM131729)
Howard Hughes Medical Institute (GT12053)
Cystic Fibrosis Foundation (WETZEL21F0)
Association Vaincre la Mucoviscidose (RF20200502678)
Agence Nationale de la Recherche (ANR-21-CE44-0027-01, ANR-21-CE44-0027-01)
- License Information
-
More Information
Article History
Received: 14 March 2023
Accepted: 17 July 2023
First Online: 24 August 2023
Competing interests
: GFH receives support through a Collaborative Research Agreement with Janssen Inc., which did not fund the work reported here. The remaining authors declare no competing interests.
